Article thumbnail

Are Toll-Like Receptors and Decoy Receptors Involved in the Immunopathogenesis of Systemic Lupus Erythematosus and Lupus-Like Syndromes?

By Giuliana Guggino, Anna Rita Giardina, Francesco Ciccia, Giovanni Triolo, Francesco Dieli and Guido Sireci

Abstract

In this paper we focus our attention on the role of two families of receptors, Toll-like receptors (TLR) and decoy receptors (DcR) involved in the generation of systemic lupus erythematosus (SLE) and lupus-like syndromes in human and mouse models. To date, these molecules were described in several autoimmune disorders such as rheumatoid arthritis, antiphospholipids syndrome, bowel inflammation, and SLE. Here, we summarize the findings of recent investigations on TLR and DcR and their role in the immunopathogenesis of the SLE

Topics: Review Article
Publisher: Hindawi Publishing Corporation
OAI identifier: oai:pubmedcentral.nih.gov:3157161
Provided by: PubMed Central

Suggested articles

Citations

  1. (2011). Activation of dendritic cells via TLR7 reduces Foxp3 expression and suppressive function in induced Tregs,”
  2. (2007). Akahoshi et al., “Protection against autoimmune nephritis
  3. (2007). BAFF and MyD88 signals promote a lupuslike disease independent of T cells,”
  4. (2011). BAFF inhibition: a new class of drugs for the treatment of autoimmunity,”
  5. (2006). Clearance of apoptotic cells
  6. (2003). Clinical significance of detecting elevated serum DcR3/TR6/M68 in malignant tumor patients,”
  7. (2003). DcR3/TR6 modulates immune cell interactions,”
  8. (2000). Death, autoantigen modifications, and tolerance,”
  9. (2001). Decoy receptors: a strategy to regulate inflammatory cytokines and chemokines,”
  10. (2011). Differential development of plasmacytoid dendritic cells in
  11. (1998). e r r m a n n ,R .E .V o l l ,O .M .Z o l l e r ,M .H a g e n h o f e r
  12. (2003). Expression and regulation of toll-like receptor 2 in rheumatoid arthritis synovium,”
  13. (2004). Expression of toll-like receptors 2 and 4 in rheumatoid synovial tissue and regulation by proinflammatory cytokines
  14. (2010). Expression of Tolllike receptor 3 and Toll-like receptor 7 in muscle is characteristic of inflammatory myopathy and is differentially regulated by
  15. Foxp3+ regulatory T cells of psoriasis patients easily differentiate into IL-17Aproducing cells and are found in lesional skin,” Journal of Investigative Dermatology.
  16. (2009). G r e e n ,T .F e r g u s o n ,L .Z i t v o g e l ,a n dG .K r o e m e r , “Immunogenic and tolerogenic cell death,”
  17. (2009). Human dendritic cells stimulated via TLR7 and/or TLR8 induce the sequential production of
  18. (2007). Inhibition of Toll-like receptor-7 (TLR-7) or TLR-7 plus TLR-9 attenuates glomerulonephritis and lung injury in experimental lupus,” J o u r n a lo ft h eA m e r i -can
  19. (2010). Invariant NKT cells limit activation of autoreactive CD1d-positive B cells,”
  20. (2008). Natural regulatory T cells: number and function are normal in the majority of patients with lupus nephritis,”
  21. (2007). Overexpression of human decoy receptor 3 in mice results in a systemic lupus erythematosus-like syndrome,”
  22. (2006). Pathogen recognition and innate immunity,”
  23. (1985). Progenitors for Ly-1 B cells are distinct from progenitors for other B cells,”
  24. (2011). Role for toll-like receptors in autoimmune disease: the example of systemic lupus erythematosus,”
  25. (2008). Role of the chemokine decoy receptor D6 in balancing inflammation, immune activation, and antimicrobial resistance in Mycobacterium tuberculosis infection,”
  26. (2010). Targeting toll-like receptors for treatment of SLE,”
  27. (2006). The role of Toll-like receptors in systemic lupus erythematosus,”
  28. TLR stimulation modifies BLyS receptor expression in follicular and marginal zone
  29. (2006). TLR4 up-regulation at protein or gene level is pathogenic for lupus-like autoimmune disease,”
  30. (2006). Toll-like receptor 7 and TLR9 dictate autoantibody specificity and have opposing inflammatory and regulatory roles in a murine model of lupus,”
  31. (2007). Toll-like receptors and innate immune responses in systemic lupus erythematosus,”
  32. (2010). Transgenic overexpression of anti-double-stranded DNA autoantibody and activation of toll-like receptor 4 in mice induce severe systemic lupus erythematosus syndromes,”
  33. (2009). Tuning inflammation in tuberculosis: the role of decoy receptors,”
  34. (2010). Updating on the pathogenesis of systemic lupus erythematosus,”AutoimmunityReviews,vol.10,no.1,pp.3–7,

To submit an update or takedown request for this paper, please submit an Update/Correction/Removal Request.